GlassScriptPhysician profile
Sandy Wingyi Cheung
NPI 1871952523
$6,787.36
in general payments reported to CMS, 2019-2025
18 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $239 · 2022: $506 · 2023: $5,286 · 2024: $527 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,513 · Education: $2,000 · Food and Beverage: $1,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,512.99 |
| Education | $2,000.00 |
| Food and Beverage | $1,530.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,690.34 | 2023 | Da Vinci Surgical System, Da Vinci Sp |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $498.75 | 2021-2025 | Xifaxan |
| Gilead Sciences, INC. | $450.51 | 2021-2025 | Epclusa |
| Abbvie INC. | $343.97 | 2021-2024 | |
| Intra-Sana Laboratories | $200.00 | 2022 | |
| Phathom Pharmaceuticals, INC. | $198.46 | 2024 | Voquezna |
| Aimmune Therapeutics, INC. | $99.55 | 2024-2025 | Zenpep |
| Pfizer INC. | $71.07 | 2023-2024 | |
| Ardelyx, INC. | $49.70 | 2022-2023 | Ibsrela |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.60 | 2023 | Cyltezo |
| Chiesi USA, INC. | $27.23 | 2021 | |
| Intercept Pharmaceuticals, INC. | $21.08 | 2021 | |
| Merck Sharp & Dohme LLC | $20.61 | 2022 | |
| Nestle Healthcare Nutrition INC. | $18.47 | 2023 | |
| Redhill Biopharma INC. | $18.26 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $17.19 | 2021 | |
| Janssen Biotech, INC. | $16.91 | 2023 | Stelara |
| Boston Scientific Corporation | $16.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Cheung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.